-
Value in Health : the Journal of the... Jan 2022Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic... (Review)
Review
Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.
Topics: Checklist; Cost-Benefit Analysis; Economics, Medical; Humans; Publishing; Research Design
PubMed: 35031096
DOI: 10.1016/j.jval.2021.11.1351 -
Journal of Plastic, Reconstructive &... Dec 2020This editorial explores value in relation to plastic surgery and strategies that have been suggested to deliver value-based healthcare. We consider how value is...
This editorial explores value in relation to plastic surgery and strategies that have been suggested to deliver value-based healthcare. We consider how value is measured, accounting for patient outcomes and experiences, costs and equity, and describe strategies that might improve value, such as outcome-based reimbursement, reporting transparency and high volume specialist centres.
Topics: Delivery of Health Care; Health Care Costs; Humans; Quality of Health Care; Surgery, Plastic; Value-Based Purchasing
PubMed: 32859568
DOI: 10.1016/j.bjps.2020.08.019 -
Annals of Internal Medicine Jan 2020This paper is part of the American College of Physicians' policy framework to achieve a vision for a better health care system, where everyone has coverage for and...
This paper is part of the American College of Physicians' policy framework to achieve a vision for a better health care system, where everyone has coverage for and access to the care they need, at a cost they and the country can afford. Currently, the United States is the only wealthy industrialized country that has not achieved universal health coverage. The nation's existing health care system is inefficient, unaffordable, unsustainable, and inaccessible to many. Part 1 of this paper discusses why the United States needs to do better in addressing coverage and cost. Part 2 presents 2 potential approaches, a single-payer model and a public choice model, to achieve universal coverage. Part 3 describes how an emphasis on value-based care can reduce costs.
Topics: Delivery of Health Care; Health Care Reform; Health Policy; Health Services Accessibility; Health Services Needs and Demand; Healthcare Disparities; Humans; Insurance, Health; Models, Economic; Societies, Medical; United States; Universal Health Insurance
PubMed: 31958805
DOI: 10.7326/M19-2415 -
Diabetes Care Jul 2020The convergence of advances in medical science, human biology, data science, and technology has enabled the generation of new insights into the phenotype known as... (Review)
Review
The convergence of advances in medical science, human biology, data science, and technology has enabled the generation of new insights into the phenotype known as "diabetes." Increased knowledge of this condition has emerged from populations around the world, illuminating the differences in how diabetes presents, its variable prevalence, and how best practice in treatment varies between populations. In parallel, focus has been placed on the development of tools for the application of precision medicine to numerous conditions. This Consensus Report presents the American Diabetes Association (ADA) Precision Medicine in Diabetes Initiative in partnership with the European Association for the Study of Diabetes (EASD), including its mission, the current state of the field, and prospects for the future. Expert opinions are presented on areas of precision diagnostics and precision therapeutics (including prevention and treatment), and key barriers to and opportunities for implementation of precision diabetes medicine, with better care and outcomes around the globe, are highlighted. Cases where precision diagnosis is already feasible and effective (i.e., monogenic forms of diabetes) are presented, while the major hurdles to the global implementation of precision diagnosis of complex forms of diabetes are discussed. The situation is similar for precision therapeutics, in which the appropriate therapy will often change over time owing to the manner in which diabetes evolves within individual patients. This Consensus Report describes a foundation for precision diabetes medicine, while highlighting what remains to be done to realize its potential. This, combined with a subsequent, detailed evidence-based review (due 2022), will provide a roadmap for precision medicine in diabetes that helps improve the quality of life for all those with diabetes.
Topics: Biomedical Research; Consensus; Diabetes Mellitus; Endocrinology; Europe; Evidence-Based Medicine; Expert Testimony; Financial Management; Health Plan Implementation; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Precision Medicine; Quality of Life; Societies, Medical; United States
PubMed: 32561617
DOI: 10.2337/dci20-0022 -
BMJ Supportive & Palliative Care Sep 2021
Topics: Decision Making; Economics, Medical; Humans; Terminal Care
PubMed: 33685946
DOI: 10.1136/bmjspcare-2020-002388 -
Value in Health : the Journal of the... Jan 2022Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic...
Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces the previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, and the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as healthcare, public health, education, and social care). This Explanation and Elaboration Report presents the new CHEERS 2022 28-item checklist with recommendations and explanation and examples for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer-reviewed journals and the peer reviewers and editors assessing them for publication. Nevertheless, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, given that there is an increasing emphasis on transparency in decision making.
Topics: Biomedical Research; Checklist; Cost-Benefit Analysis; Economics, Medical; Female; Humans; Peer Review; Research Personnel; Stakeholder Participation
PubMed: 35031088
DOI: 10.1016/j.jval.2021.10.008 -
Journal of Investigative Medicine : the... Jan 2021
Topics: Animals; Biomedical Research; Humans; Research Design; Research Personnel
PubMed: 33318056
DOI: 10.1136/jim-2020-001741 -
British Journal of Hospital Medicine... Apr 2024The anaesthetic training programme in the United Kingdom (UK) spans over seven years and is overseen by the Royal College of Anaesthetists (RCOA). Junior doctors in... (Review)
Review
The anaesthetic training programme in the United Kingdom (UK) spans over seven years and is overseen by the Royal College of Anaesthetists (RCOA). Junior doctors in England are currently striking amid ongoing pay negotiations with the government, and almost all junior doctors are worried about the cost of living. This article provides an overview of the average financial cost of training for doctors in the anaesthetic training programme. The cost incurred by anaesthetic trainees illustrates the level of financial burden faced by trainees across multiple specialities. The cost includes: student loan repayment (with interest rates), compulsory membership fees (including the Royal College of Anaesthetists and General Medical Council), postgraduate examinations (Fellowship of the Royal College of Anaesthetist exams are compulsory to complete training) and medical indemnity. The average trainee spends between 5.6% and 7.4% of their annual salary on non-reimbursable costs. This article delineates for aforementioned expenses and compares them with the training programs in Australia and New Zealand, given their status as frequent emigration destinations for UK doctors.
Topics: Humans; Anesthesiology; United Kingdom; Education, Medical, Graduate; Australia; New Zealand; Salaries and Fringe Benefits
PubMed: 38708973
DOI: 10.12968/hmed.2023.0437 -
Praxis 2020
Topics: Economics, Medical; Medicine
PubMed: 32126923
DOI: 10.1024/1661-8157/a003434